UCB SA (EBR:UCB)
Belgium · Delayed Price · Currency is EUR 208.10
-0.50 (-0.24%)
Sep 18, 2026, 5:35 PM CET
UCB SA Market Cap
UCB SA has a market cap or net worth of €39.68 billion as of September 18, 2026. Its market cap has increased by 2.87% in one year.
Market Cap
39.68B
Enterprise Value
42.50B
Revenue
8.52B
Ranking
n/a
PE Ratio
18.38
Stock Price
€208.10
ChartMarket Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 890.67M to 39.68B, an increase of 4,354.74%. That is a compound annual growth rate of 12.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 39.68B | -12.48% |
| Dec 31, 2025 | 45.33B | 24.32% |
| Dec 31, 2024 | 36.46B | 143.60% |
| Dec 29, 2023 | 14.97B | 7.12% |
| Dec 30, 2022 | 13.97B | -26.25% |
| Dec 31, 2021 | 18.95B | 18.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 54.28B |
| Financière de Tubize | 7.88B |
| Onward Medical | 200.94M |
| Hyloris Pharmaceuticals | 117.60M |
| European Medical Solutions | 16.50M |
| Celyad Oncology | 10.79M |
| BioSenic | 1.31M |
| Oxurion NV | 309.62K |